Evidence map›Paper›PMID 23927692›Full record

ArticleAnalytical chemistry2013

Pharmacological mitigation of tissue damage during brain microdialysis.

Kathryn M Nesbitt, Andrea Jaquins-Gerstl, Erin M Skoda, Peter Wipf, Adrian C Michael

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Dexamethasone-Enhanced Microdialysis and Penetration Injury.Frontiers in bioengineering and biotechnology · 2020
    Review
  14. Article
  15. A rotating operant chamber for use with microdialysis.Journal of neuroscience methods · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Methods of Measuring Enzyme Activity Ex Vivo and In Vivo.Annual review of analytical chemistry (Palo Alto, Calif.) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kathryn M NesbittDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
Andrea Jaquins-Gerstl
Erin M Skoda
Peter Wipf
Adrian C Michael
University of Pittsburgh · US

Funding

University of Pittsburgh Center for Chemical DiversityP50GM067082 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WIPF, PETER · 2002 to 2012
$18.6M
Ultrastructural Basis of Neurochemical Measures in BrainR01MH075989 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MICHAEL, ADRIAN C · 2007 to 2011
$1.5M
Neuroprotection of Dopamine During MicrodialysisR21NS081744 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MICHAEL, ADRIAN C · 2013 to 2014
$419k
NIGMS NIH HHS P50 GM067082NIMH NIH HHS MH 075989NIMH NIH HHS R01 MH075989NINDS NIH HHS NS 081744NINDS NIH HHS R21 NS081744
6 · The paper itself

Abstract

Microdialysis sampling in the brain is employed frequently in the chemical analysis of neurological function and disease, but implanting the probes, which are substantially larger than the size and spacing of brain cells and blood vessels, is injurious and triggers ischemia, gliosis, and cell death at the sampling site. The nature of the interface between the brain and the microdialysis probe is critical to the use of microdialysis as a neurochemical analysis technique. The objective of the work reported here was to investigate the potential of two compounds, dexamethasone, a glucocorticoid anti-inflammatory agent, and XJB-5-131, a mitochondrially targeted reactive oxygen species scavenger, to mitigate the penetration injury. Measurements were performed in the rat brain striatum, which is densely innervated by axons that release dopamine, an electroactive neurotransmitter. We used voltammetry to measure electrically evoked dopamine release next to microdialysis probes during the retrodialysis of dexamethasone or XJB-5-131. After the in vivo measurements, the brain tissue containing the microdialysis probe tracks was examined by fluorescence microscopy using markers for ischemia, neuronal nuclei, macrophages, and dopamine axons and terminals. Dexamethasone and XJB-5-131 each diminished the loss of evoked dopamine activity, diminished ischemia, diminished the loss of neuronal nuclei, diminished the appearance of extravasated macrophages, and diminished the loss of dopamine axons and terminals next to the probes. Our findings confirm the ability of dexamethasone and XJB-5-131 to mitigate, but not eliminate, the effects of the penetration injury caused by implanting microdialysis probes into brain tissue.

Indexed as

AnimalsBrainCyclic N-OxidesDexamethasoneDopamineHead Injuries, PenetratingMicrodialysisRatsCyclic N-OxidesDexamethasoneDopamineXJB-5-131

Identifiers

PMID23927692
PMCPMC3799822
OpenAlexW2022580018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.